 12. Currently treated with a strong CYP3A4 inhibitor e.g., erythromycin, ketoconazole, itraconazol, voriconazol, clarithromycin, telithromycin, ritonavir, mibefradil, and the treatment cannot be stopped or switched to other drug before the start of study drug administration For a complete list, refer to this link: 